Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1666) 1666
Book Chapter (37) 37
Book / eBook (12) 12
Dissertation (5) 5
Trade Publication Article (5) 5
Conference Proceeding (2) 2
Paper (2) 2
Book Review (1) 1
Magazine Article (1) 1
Newsletter (1) 1
Publication (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1115) 1115
life sciences & biomedicine (1073) 1073
humans (759) 759
pharmacology & pharmacy (597) 597
extended release (517) 517
male (515) 515
delayed-action preparations (496) 496
female (461) 461
adult (372) 372
middle aged (340) 340
biological and medical sciences (301) 301
medical sciences (299) 299
pharmacology. drug treatments (265) 265
extended-release (263) 263
aged (206) 206
treatment outcome (204) 204
double-blind method (188) 188
neurosciences & neurology (181) 181
pharmacokinetics (180) 180
psychiatry (177) 177
clinical neurology (170) 170
analysis (164) 164
adolescent (153) 153
tablets (145) 145
young adult (132) 132
drug therapy (131) 131
care and treatment (124) 124
drug administration schedule (121) 121
cross-over studies (111) 111
opioids (107) 107
drug delivery systems (106) 106
dose-response relationship, drug (103) 103
delayed-action preparations - administration & dosage (102) 102
chemistry, pharmaceutical (101) 101
drugs (100) 100
solubility (100) 100
analgesics, opioid - administration & dosage (99) 99
general pharmacology (98) 98
clinical trials (97) 97
administration, oral (94) 94
dosage and administration (93) 93
research (90) 90
animals (89) 89
general & internal medicine (85) 85
naltrexone (84) 84
pharmaceutical technology. pharmaceutical industry (84) 84
medicine, general & internal (82) 82
area under curve (80) 80
physical sciences (80) 80
substance abuse (78) 78
time factors (78) 78
narcotics (77) 77
efficacy (74) 74
neuropharmacology (74) 74
pain (72) 72
chemistry (71) 71
drug dosages (70) 70
psychology. psychoanalysis. psychiatry (70) 70
extended-release naltrexone (69) 69
aged, 80 and over (68) 68
schizophrenia (68) 68
safety (67) 67
biological availability (66) 66
delayed-action preparations - pharmacokinetics (65) 65
quality of life (63) 63
analgesics, opioid - adverse effects (59) 59
delayed-action preparations - chemistry (59) 59
delayed-action preparations - therapeutic use (58) 58
pharmacology (58) 58
dissolution (57) 57
drug therapy, combination (57) 57
psychopharmacology (57) 57
bioavailability (56) 56
chronic pain (55) 55
medicine, research & experimental (55) 55
randomized controlled trials as topic (55) 55
research & experimental medicine (55) 55
internal medicine (54) 54
original research (54) 54
psychopathology. psychiatry (54) 54
analgesics, opioid - therapeutic use (53) 53
prospective studies (53) 53
chemistry, medicinal (52) 52
patients (52) 52
review (52) 52
child (51) 51
neurosciences (51) 51
medical research (50) 50
chemistry, multidisciplinary (49) 49
adult and adolescent clinical studies (48) 48
epilepsy (48) 48
pharmacology/toxicology (48) 48
analgesics (47) 47
kinetics (47) 47
social sciences (47) 47
antipsychotic agents - administration & dosage (46) 46
drug combinations (46) 46
extended-release niacin (46) 46
medicine, experimental (46) 46
naltrexone - administration & dosage (46) 46
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1674) 1674
Spanish (16) 16
German (15) 15
Japanese (12) 12
Portuguese (12) 12
Russian (11) 11
French (7) 7
Turkish (7) 7
Chinese (4) 4
Croatian (3) 3
Hungarian (3) 3
Korean (3) 3
Czech (2) 2
Polish (2) 2
Slovenian (2) 2
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Oral controlled release formulation design and drug delivery
: theory to practice
by Park, Kinam and Wen, Hong, 1967
2010, 1. Aufl., ISBN 9780470253175, x, 363
Drugs | Administration, Oral | Oral medication | Delayed-Action Preparations | Controlled release | Drug Design | Chemistry | Organic | SCIENCE
Book
Details down arrow
2. Full Text Current long-term pharmacotherapies for the management of obesity
by Kim, Bo-Yeon and Kang, Seon Mee and Kang, Jee-Hyun and Kim, Kyoung Kon and Kim, Bomtaeck and Kim, Seung Jun and Kim, Yang-Hyun and Kim, Jung-Hwan and Kim, Jae Hyun and Nam, Ga Eun and Park, Ji Yeon and Son, Jang Won and Shin, Hye-Jung and Oh, Tae Jung and Lee, Hyug and Jeon, Eon-Ju and Chung, Sochung and Hong, Yong Hee and Kim, Chong Hwa and Committee of Clinical Practice Guidelines, Korean Society for the Study of Obesity (KSSO)
Journal of obesity & metabolic syndrome, ISSN 2508-6235, 06/2020, Volume 29, Issue 2, pp. 99 - 109
Naltrexone/bupropion extended-release | Orlistat | Obesity | Phentermine/ topiramate extended-release | Lorcaserin | Liraglutide | Phentermine | topiramate extended-release | Review | bupropion extended-release | Naltrexone | liraglutide | lorcaserin | phentermine/topiramate extended-release | naltrexone/bupropion extended-release | orlistat | obesity
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Determinants of interest in extended-released buprenorphine: A survey among 366 French patients treated with buprenorphine or methadone
by Rolland, Benjamin and Trojak, Benoit and Nourredine, Mikail and Bachellier, Jérôme and Chappuy, Mathieu and Bendimerad, Patrick and Kosim, Margaux and Hjelmström, Peter and Meroueh, Fadi and Nubukpo, Philippe and Brousse, Georges
Drug and alcohol dependence, ISSN 0376-8716, 03/2021, Volume 220, p. 108492
Patients' preference | Extended-release | Survey | Buprenorphine | France
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text A clinical protocol of a comparative effectiveness trial of extended-release naltrexone versus extended-release buprenorphine with individuals leaving jail
by Gordon, Michael S and Mitchell, Shannon Gwin and Blue, Thomas R and Vocci, Frank J and Fishman, Marc J and Murphy, Sean M and Couvillion, Kathy and Maher, Kelly and Ryan, Danielle and Wenzel, Kevin and Danner, Martha L and Jarvis, Daniel K
Journal of substance abuse treatment, 12/2020, pp. 108241 - 108241
Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Delivery and controlled release of bioactives in foods and nutraceuticals
by Garti, Nissim
2008, Woodhead Publishing Series in Food Science, Technology and, ISBN 1420074369, xvii, 478
Additifs | Functional foods | Bioactive compounds | Food additives | Composés bioactifs | Nutraceutiques | Aliments | Controlled release technology
Book
Details down arrow
6. Modified-release drug delivery technology
by Rathbone, Michael J., 1957
2008, 2nd ed., Drugs and the pharmaceutical sciences, ISBN 9781420044355, Volume 183-184, 2 v.
Controlled release preparations | Technology, Pharmaceutical | Controlled release technology | Delayed-Action Preparations | Drug Delivery Systems
Book
Details down arrow
7. Full Text Extended‐release injectable naltrexone (XR‐NTX): a response to clinical issues raised by Brewer & Streel
by Jarvis, Brantley P and Holtyn, August F and Subramaniam, Shrinidhi and Tompkins, D. Andrew and Oga, Emmanuel A and Bigelow, George and Silverman, Kenneth
Addiction (Abingdon, England), ISSN 0965-2140, 01/2019, Volume 114, Issue 1, pp. 189 - 190
opioid use disorder | injectable | naltrexone | heroin | prescription opioids | medication‐assisted treatment | Extended‐release | Extended-release | medication-assisted treatment | Naltrexone
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Reductions in reported deaths following the introduction of extended‐release oxycodone (OxyContin) with an abuse‐deterrent formulation
by Sessler, Nelson E and Downing, Jerod M and Kale, Hrishikesh and Chilcoat, Howard D and Baumgartner, Todd F and Coplan, Paul M
Pharmacoepidemiology and drug safety, ISSN 1053-8569, 12/2014, Volume 23, Issue 12, pp. 1238 - 1246
extended‐release oxycodone | overdose death | pharmacovigilance | OxyContin | abuse‐deterrent | pharmacoepidemiology | Pharmacoepidemiology | Abuse-deterrent | Pharmacovigilance | Extended-release oxycodone | Overdose death | Pharmacology & Pharmacy | Public, Environmental & Occupational Health | Life Sciences & Biomedicine | Science & Technology | Biological and medical sciences | Medical sciences | General pharmacology | Clinical trial. Drug monitoring | Pharmacology. Drug treatments | Oxycodone - administration & dosage | United States | Humans | Middle Aged | Male | Mortality - trends | Oxycodone - chemistry | Chemistry, Pharmaceutical - standards | Database Management Systems | Adolescent | Adult | Female | Aged | Dosage Forms | Child | Delayed-Action Preparations | Chemistry, Pharmaceutical - trends | Drug abuse | Surveillance equipment | Analysis | Opioids | Fatalities | Narcotics | Analgesics | Index Medicus | abuse-deterrent | Original Reports | extended-release oxycodone
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Prediction of in vivo performance of oral extended release formulations prior to clinical evaluation: A case study for enteric coated polymeric beads formulation
by Xu, Jin and Lin, Yiqing and Zawaneh, Peter N and Nestorov, Ivan and Leung, Cheuk-Yui and Boulas, Pierre
European journal of pharmaceutics and biopharmaceutics, ISSN 0939-6411, 01/2021, Volume 158, pp. 222 - 232
Formulation development | Extended release | Biopredictive | Enteric coated | Level A IVIVC
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Extended‐release injectable naltrexone for opioid use disorder: a systematic review
by Jarvis, Brantley P and Holtyn, August F and Subramaniam, Shrinidhi and Tompkins, D. Andrew and Oga, Emmanuel A and Bigelow, George E and Silverman, Kenneth
Addiction (Abingdon, England), ISSN 0965-2140, 07/2018, Volume 113, Issue 7, pp. 1188 - 1209
opioid use disorder | injectable | naltrexone | heroin | prescription opioids | medication‐assisted treatment | Extended‐release | Extended-release | medication-assisted treatment | Life Sciences & Biomedicine | Substance Abuse | Psychiatry | Science & Technology | Naltrexone - therapeutic use | Medication Adherence | Narcotic Antagonists - administration & dosage | Opioid-Related Disorders - drug therapy | Narcotic Antagonists - therapeutic use | Drug Overdose | Humans | Analgesics, Opioid - poisoning | Treatment Outcome | Injections, Intramuscular | Delayed-Action Preparations | Naltrexone - administration & dosage | Drugs | Medical research | Buprenorphine | Detoxification (Substance abuse treatment) | Medicine, Experimental | Medical records | Overdose | Naltrexone | Substance abuse treatment | Retrospective studies | Systematic review | Retention | Evidence-based medicine | Confidence intervals | Literature reviews | Randomization | Opioids | Judicial system | Search engines | Helpseeking | Release | Drug addiction | Narcotics | Induction | Criminal justice | Health services utilization | Detoxification | Efficacy | Scientific papers | Crime | Demonstrations | Adults | Prisoners | Substance abuse disorders | Index Medicus | extended-release
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Duration of benefit per Dose: Carbidopa-Levodopa immediate release vs. extended release capsules (Rytary®)
by Hauser, Robert A and Zeitlin, Leonid and Fisher, Stanley and D'Souza, Richard
Parkinsonism & related disorders, ISSN 1353-8020, 01/2021, Volume 82, pp. 133 - 137
Extended release | Parkinson's disease | Treatment | Levodopa | Rytary | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Opioid treatment at release from jail using extended‐release naltrexone: a pilot proof‐of‐concept randomized effectiveness trial
by Lee, Joshua D and McDonald, Ryan and Grossman, Ellie and McNeely, Jennifer and Laska, Eugene and Rotrosen, John and Gourevitch, Marc N
Addiction (Abingdon, England), ISSN 0965-2140, 06/2015, Volume 110, Issue 6, pp. 1008 - 1014
relapse prevention | Extended‐release naltrexone | prisoners | jail | Vivitrol | opioid dependence | randomized controlled trial | Extended-release naltrexone | Opioid dependence | Jail | Randomized controlled trial | Relapse prevention | Prisoners | Life Sciences & Biomedicine | Substance Abuse | Psychiatry | Science & Technology | Recurrence | Narcotic Antagonists - administration & dosage | Humans | Male | Treatment Outcome | Injections, Intramuscular | New York City | Opioid-Related Disorders - rehabilitation | Pilot Projects | Adult | Delayed-Action Preparations | Naltrexone - administration & dosage | Adults | Cocaine | Buprenorphine | Naltrexone | Urine | Confidence intervals | Prisons | Imprisonment | Narcotics | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Novel formulations and modes of delivery of levodopa
by Poewe, Werner and Antonini, Angelo
Movement disorders, ISSN 0885-3185, 01/2015, Volume 30, Issue 1, pp. 114 - 120
extended‐release formulation | levodopa microtablets | levodopa infusions | COMT inhibitors | intrapulmonary delivery | Levodopa microtablets | Intrapulmonary delivery | Extended-release formulation | Levodopa infusions | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Animals | Levodopa - administration & dosage | Humans | Antiparkinson Agents - administration & dosage | Parkinson Disease - drug therapy | Carbidopa - administration & dosage | Drug Combinations | Drug Delivery Systems | Drugs | Drug delivery systems | Enzyme inhibitors | Dopa | Vehicles | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text World Workshop on Oral Medicine VI: clinical implications of medication-induced salivary gland dysfunction
by Aliko, Ardita, DDS, PhD and Wolff, Andy, DMD and Dawes, Colin, BDS, PhD and Aframian, Doron, DDS, PhD and Proctor, Gordon, BSc, PhD and Ekström, Jörgen, MD, PhD and Narayana, Nagamani, DMD, MS and Villa, Alessandro, DDS, PhD, MPH and Sia, Ying Wai, DMD and Joshi, Revan Kumar, MDS and McGowan, Richard, MLS and Beier Jensen, Siri, DDS, PhD and Kerr, A. Ross, DDS, MSD and Lynge Pedersen, Anne Marie, DDS, PhD and Vissink, Arjan, MD, DMD, PhD and Sahlgrenska akademin and Institute of Neuroscience and Physiology, Department of Pharmacology and Göteborgs universitet and Institutionen för neurovetenskap och fysiologi, sektionen för farmakologi and Gothenburg University and Sahlgrenska Academy
Oral surgery, oral medicine, oral pathology and oral radiology, ISSN 2212-4403, 2015, Volume 120, Issue 2, pp. 185 - 206
Surgery | OVERACTIVE BLADDER SYNDROME | CANNABIS-BASED MEDICINE | TOLTERODINE EXTENDED-RELEASE | GENERALIZED ANXIETY DISORDER | SJOGRENS-SYNDROME PATIENTS | RESTLESS LEGS SYNDROME | LONG-TERM SAFETY | RANDOMIZED CONTROLLED-TRIAL | PLACEBO-CONTROLLED TRIAL | MAJOR DEPRESSIVE DISORDER | Life Sciences & Biomedicine | Dentistry, Oral Surgery & Medicine | Science & Technology | Salivary Gland Diseases - chemically induced | Salivation - drug effects | Humans | Risk Factors | Index Medicus | Dentistry | Odontologi | TOLTERODINE | DISORDER | MAJOR DEPRESSIVE | EXTENDED-RELEASE
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights